JF
LXRX icon

Jump Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jump Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,246
Closed -$62.8K – 2288
2026
Q1 		$62.8K Buy
+40,246
New +$58.5K ﹤0.01% 1780
2025
Q3 		– Sell
-15,993
Closed -$15.1K – 2042
2025
Q2 		$15.1K Buy
+15,993
New +$10.4K ﹤0.01% 1741
2023
Q3 		– Sell
-19,280
Closed -$44.2K – 2089
2023
Q2 		$44.2K Buy
19,280
+1,080
+6% +$2.87K ﹤0.01% 1729
2023
Q1 		$44.2K Buy
+18,200
New +$41.7K ﹤0.01% 1499
2022
Q1 		– Sell
-38,700
Closed -$152K – 1744
2021
Q4 		$152K Buy
+38,700
New +$188K 0.01% 1161

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jump Financial's LXRX Position: Q2 2026 in Review

Jump Financial sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 40,246 shares — an estimated $62.8K sold.

Jump Financial first reported a position in LXRX in Q4 2021 and held it in 5 quarters. The position peaked at $152K in Q4 2021. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Jump Financial reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 40,246 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $62.8K.
  • Jump Financial first reported a position in Lexicon Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Jump Financial's Lexicon Pharmaceuticals position peaked at $152K in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.